The Doppler Veterinary Ultrasound segmentation by application distinguishes four principal use‑cases that collectively drive market revenue. Cardiovascular imaging, accounting for roughly 38 % of sales, is the largest segment because it enables real‑time flow quantification in dogs, cats, and equine patients, directly influencing diagnostic protocols for congenital and acquired heart disease. Reproductive applications, representing about 27 % of the market, support breeding programs through follicular monitoring and fetal viability assessment, a niche with high repeat‑purchase rates for specialized probes. Musculoskeletal use, estimated at 22 %, provides clinicians with Doppler‑enhanced evaluation of tendon vascularity and joint inflammation, expanding the technology’s relevance beyond traditional imaging. Abdominal diagnostics, contributing the remaining 13 %, are employed for hepatic and renal perfusion studies, where Doppler data complement B‑mode findings. Each application segment adds a distinct revenue stream, reflecting differing equipment configurations, software licensing, and service contracts, thereby shaping the overall market size.